Biogen Co-op: Product Development & Commercialization in Cambridge, Massachusetts
/This position is a 6-month Co-op from January – June 2022/ The Multiple Sclerosis (MS) Product Development & Commercialization (PDC) team leads the development and communication of product strategy across Biogen’s Multiple Sclerosis product franchise. TYSABRI is a monoclonal antibody therapy used to treat Multiple Sclerosis. The TYSABRI PDC has a series of Life-Cycle Management initiatives that are being evaluated for integration into the current product offering. You will participate as a key member of the Life Cycle Management team. Additionally, you will assist in the development of a competitive response strategy for a new competitor expected in Q4 2022. Position Description As a Co-op on the TYSABRI PDC team you will assist with the Strategy Development and implementation of the Life Cycle management process. Key aspects of this role include but are not limited to: * End to end process development and communication. * Develop and maintain a department level dashboard communicating Life Cycle management initiatives, investment, and status. * Engagement with Regional partners (Europe, US, Rest of World) to identify specific regional needs for inclusion in Life Cycle Management process * Meeting management and communication Day to day responsibilities * Coordination among Product Development & Commercialization team members to ensure representation (Medical, Research & Development, Manufacturing, Finance) * Manage and execute Summit series for Competitive response strategy To participate in the Biogen Internship Program, students must meet the following eligibility criteria: * Legal authorization to work in the U.S. * At least 18 years of age prior to the scheduled start date * Be currently enrolled in an accredited college or university Education Masters Level with related focus on business, does not have to be an MBA track All your information will be kept confidential according to EEO guidelines.